KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Inventory (2016 - 2026)

Pacira BioSciences has reported Change in Inventory over the past 17 years, most recently at -$2.5 million for Q1 2026.

  • For Q1 2026, Change in Inventory fell 129.4% year-over-year to -$2.5 million; the TTM value through Mar 2026 reached $16.6 million, down 55.09%, while the annual FY2025 figure was $27.6 million, 31.72% up from the prior year.
  • Change in Inventory for Q1 2026 was -$2.5 million at Pacira BioSciences, up from -$4.8 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $14.4 million in Q2 2025 and troughed at -$7.6 million in Q1 2024.
  • A 5-year average of $3.0 million and a median of $4.4 million in 2023 define the central range for Change in Inventory.
  • On a YoY basis, Change in Inventory climbed as much as 11988.37% in 2022 and fell as far as 567.17% in 2022.
  • Year by year, Change in Inventory stood at -$735000.0 in 2022, then surged by 1165.71% to $7.8 million in 2023, then skyrocketed by 71.29% to $13.4 million in 2024, then tumbled by 135.9% to -$4.8 million in 2025, then surged by 48.29% to -$2.5 million in 2026.
  • Business Quant data shows Change in Inventory for PCRX at -$2.5 million in Q1 2026, -$4.8 million in Q4 2025, and $9.5 million in Q3 2025.